GCM
CCRN icon

Gladius Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Gladius Capital Management’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,985
Closed -$53.6K – 103
2024
Q3 		$53.6K Buy
3,985
+1,812
+83% +$26.7K 0.01% 147
2024
Q2 		$30.1K Buy
2,173
+206
+10% +$3.26K ﹤0.01% 263
2024
Q1 		$36.8K Buy
1,967
+65
+3% +$1.3K 0.01% 242
2023
Q4 		$43.1K Buy
1,902
+515
+37% +$11.2K 0.01% 195
2023
Q3 		$34.4K Buy
1,387
+356
+35% +$8.96K ﹤0.01% 259
2023
Q2 		$29K Sell
1,031
-300
-23% -$7.45K ﹤0.01% 262
2023
Q1 		$29.7K Buy
1,331
+260
+24% +$6.81K ﹤0.01% 286
2022
Q4 		$28.5K Sell
1,071
-458
-30% -$14.9K ﹤0.01% 301
2022
Q3 		$44K Sell
1,529
-1,328
-46% -$34.1K ﹤0.01% 217
2022
Q2 		$60K Buy
+2,857
New +$53.5K ﹤0.01% 237

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Gladius Capital Management's CCRN Position: Q4 2024 in Review

Gladius Capital Management sold out of Cross Country Healthcare (CCRN) in Q4 2024, closing a stake of 3,985 shares — an estimated $53.6K sold.

Gladius Capital Management first reported a position in CCRN in Q2 2022 and held it in 10 quarters. The position peaked at $60K in Q2 2022. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2024.

  • Gladius Capital Management reported no remaining Cross Country Healthcare position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,985 Cross Country Healthcare shares in Q4 2024, an estimated $53.6K.
  • Gladius Capital Management first reported a position in Cross Country Healthcare in Q2 2022 and held it in 10 quarters.
  • Gladius Capital Management's Cross Country Healthcare position peaked at $60K in Q2 2022.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.